Biocan Novel Respi, lyophilizate and suspension for injection
Live attenuated intranasal vaccine against B. bronchiseptica and canine parainfluenza (kennel cough).
|type of preparative:||Vaccines|
|target species animals:||Dog|
Live attenuated Bordetella bronchiseptica strain MSLB 3096 108.0–109.8 CFU*
Live attenuated Canine parainfluenza Type 2 virus, strain CPiV-2 Bio 15 103.5–105.8 CCID50**
*CFU: Colony forming unit
**CCID50: Cell culture infectious dose 50%
Active immunisation of dogs against kennel cough from 3 weeks of age:
To reduce clinical signs and bacterial shedding after infection with Bordetella bronchiseptica.
To reduce clinical signs and viral shedding after infection with canine parainfluenza virus.
Dosage and route of administration
A single dose from 3 weeks of age.
A single dose to be given annually.
Onset of immunity
3 days after primary vaccination for Bordetella bronchiseptica.
7 days after primary vaccination for canine parainfluenza virus.
Duration of immunity
At least 12 months.
After reconstitution with the solvent, use immediately.
Store and transport refrigerated at 2 °C – 8 °C.
Do not freeze.
Protect from light.
5 vials each 1 dose of the lyophilized part and 5x 0.5 ml diluent packed in one box.
10 vials each 1 dose of the lyophilized part and 10x 0.5 ml diluent packed in one box.
+420 517 318 598